IBDEI0TD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14488,1,5,0)
 ;;=5^Adrenal Insuff
 ;;^UTILITY(U,$J,358.3,14488,2)
 ;;=^335240
 ;;^UTILITY(U,$J,358.3,14489,0)
 ;;=249.00^^89^893^49
 ;;^UTILITY(U,$J,358.3,14489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14489,1,4,0)
 ;;=4^249.00
 ;;^UTILITY(U,$J,358.3,14489,1,5,0)
 ;;=5^Secondary DM w/o Complication
 ;;^UTILITY(U,$J,358.3,14489,2)
 ;;=^336728
 ;;^UTILITY(U,$J,358.3,14490,0)
 ;;=249.40^^89^893^48
 ;;^UTILITY(U,$J,358.3,14490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14490,1,4,0)
 ;;=4^249.40
 ;;^UTILITY(U,$J,358.3,14490,1,5,0)
 ;;=5^Secondary DM w/ Renal Complications
 ;;^UTILITY(U,$J,358.3,14490,2)
 ;;=^336732
 ;;^UTILITY(U,$J,358.3,14491,0)
 ;;=249.60^^89^893^47
 ;;^UTILITY(U,$J,358.3,14491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14491,1,4,0)
 ;;=4^249.60
 ;;^UTILITY(U,$J,358.3,14491,1,5,0)
 ;;=5^Secondary DM w/ Neuro Complications
 ;;^UTILITY(U,$J,358.3,14491,2)
 ;;=^336734
 ;;^UTILITY(U,$J,358.3,14492,0)
 ;;=257.2^^89^893^31
 ;;^UTILITY(U,$J,358.3,14492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14492,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,14492,1,5,0)
 ;;=5^Hypogonadism
 ;;^UTILITY(U,$J,358.3,14492,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,14493,0)
 ;;=255.42^^89^893^38
 ;;^UTILITY(U,$J,358.3,14493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14493,1,4,0)
 ;;=4^255.42
 ;;^UTILITY(U,$J,358.3,14493,1,5,0)
 ;;=5^Mineralcorticoid Deficient
 ;;^UTILITY(U,$J,358.3,14493,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,14494,0)
 ;;=259.50^^89^893^2
 ;;^UTILITY(U,$J,358.3,14494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14494,1,4,0)
 ;;=4^259.50
 ;;^UTILITY(U,$J,358.3,14494,1,5,0)
 ;;=5^Androgen Insensitivity,Unspec
 ;;^UTILITY(U,$J,358.3,14494,2)
 ;;=^336738
 ;;^UTILITY(U,$J,358.3,14495,0)
 ;;=275.5^^89^893^18
 ;;^UTILITY(U,$J,358.3,14495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14495,1,4,0)
 ;;=4^275.5
 ;;^UTILITY(U,$J,358.3,14495,1,5,0)
 ;;=5^Hungry Bone Syndrome
 ;;^UTILITY(U,$J,358.3,14495,2)
 ;;=^336538
 ;;^UTILITY(U,$J,358.3,14496,0)
 ;;=793.2^^89^894^3
 ;;^UTILITY(U,$J,358.3,14496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14496,1,4,0)
 ;;=4^793.2
 ;;^UTILITY(U,$J,358.3,14496,1,5,0)
 ;;=5^Abnormal Chest x-ray, other
 ;;^UTILITY(U,$J,358.3,14496,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,14497,0)
 ;;=277.6^^89^894^5
 ;;^UTILITY(U,$J,358.3,14497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14497,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,14497,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,14497,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,14498,0)
 ;;=493.92^^89^894^6
 ;;^UTILITY(U,$J,358.3,14498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14498,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,14498,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,14498,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,14499,0)
 ;;=493.20^^89^894^11
 ;;^UTILITY(U,$J,358.3,14499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14499,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,14499,1,5,0)
 ;;=5^COPD with Asthma
 ;;^UTILITY(U,$J,358.3,14499,2)
 ;;=COPD with Asthma^269964
 ;;^UTILITY(U,$J,358.3,14500,0)
 ;;=493.91^^89^894^7
 ;;^UTILITY(U,$J,358.3,14500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14500,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,14500,1,5,0)
 ;;=5^Asthma, with Status Asthmat
 ;;^UTILITY(U,$J,358.3,14500,2)
 ;;=^269967
 ;;^UTILITY(U,$J,358.3,14501,0)
 ;;=491.21^^89^894^10
 ;;^UTILITY(U,$J,358.3,14501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14501,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,14501,1,5,0)
 ;;=5^COPD Exacerbation
 ;;^UTILITY(U,$J,358.3,14501,2)
 ;;=COPD Exacerbation^269954
